Valuation: Nextage Therapeutics Ltd

Market Cap 26.43M 2.64B 8.27M 7.48M 6.91M 6.25M 11.8M 778M 12.15M 82.82M 32.93M 416M 31.04M 30.38M 1.32B P/E 2024
-7.86x
P/E 2025 -5.37x
Enterprise Value 43.46M 4.35B 13.6M 12.3M 11.36M 10.28M 19.4M 1.28B 19.98M 136M 54.16M 684M 51.05M 49.96M 2.17B EV / Sales 2024
57.4x
EV / Sales 2025 12x
Free-Float
32.78%
Yield 2024 *
-
Yield 2025 -
1 day-2.40%
1 week+1.56%
Current month-9.70%
1 month-14.21%
3 months-16.41%
6 months-30.49%
Current year-58.15%
1 week 31
Extreme 31
40.9
1 month 30.7
Extreme 30.7
40.9
Current year 6.2
Extreme 6.2
99
1 year 6.2
Extreme 6.2
99
3 years 6.2
Extreme 6.2
119
5 years 6.2
Extreme 6.2
330
10 years 6.2
Extreme 6.2
600
Manager TitleAgeSince
Chief Executive Officer 42 2020-08-11
Director of Finance/CFO 63 2022-07-09
General Counsel 56 2020-08-11
Director TitleAgeSince
Chairman 87 2011-11-20
Director/Board Member 76 2014-10-12
Director/Board Member 72 2020-08-11
Change 5-day change 1-year change 3-year change Capi.($)
-2.40%+1.56%-58.15%0.00% 8.52M
+1.10%+1.03%+62.53%+70.47% 67.53B
+1.28%+8.79%+16.26%+95.16% 60.74B
+0.36%+0.67%+20.48%+99.04% 55.66B
-0.96%+10.11%+21.04%+108.91% 47.97B
-1.25%+2.77%+24.06%+38.34% 45.24B
-2.41%-11.69%+175.20%+794.72% 39.08B
+1.21%+4.75%+27.30%+52.81% 35.34B
-0.87%-1.34%+83.95%+63.96% 33.45B
-2.22%+7.34%-39.04%+397.14% 26.49B
Average -0.62%+2.83%+33.36%+172.05% 41B
Weighted average by Cap. -0.17%+2.88%+43.82%+166.69%

Financials

2024 2025
Net sales 413K 41.3M 129K 117K 108K 97.68K 184K 12.15M 190K 1.29M 515K 6.5M 485K 475K 20.66M 3.6M 360M 1.13M 1.02M 940K 851K 1.61M 106M 1.65M 11.28M 4.48M 56.65M 4.23M 4.14M 180M
Net income -3.28M -328M -1.03M -929K -858K -776K -1.47M -96.62M -1.51M -10.29M -4.09M -51.69M -3.86M -3.77M -164M -6.06M -606M -1.9M -1.72M -1.58M -1.43M -2.71M -178M -2.79M -19M -7.55M -95.44M -7.12M -6.97M -303M
Net Debt -43K -4.3M -13.46K -12.17K -11.24K -10.17K -19.2K -1.27M -19.77K -135K -53.58K -677K -50.5K -49.43K -2.15M 17.04M 1.7B 5.33M 4.82M 4.45M 4.03M 7.61M 501M 7.83M 53.39M 21.23M 268M 20.01M 19.58M 852M
Projected Income Statement - Annual - Nextage Therapeutics Ltd
Logo Nextage Therapeutics Ltd
Nextage Therapeutics Ltd, formerly known asMicromedic Technologies Ltd,is an Israel-based company engaged in the development and commercialization of cancer diagnostic products. Its portfolio includes a range of cancer and cancer-related indications including colorectal cancer, breast cancer, cervical cancer, bladder cancer, lung cancer, and diagnostic tools for personalized treatment. Micromedic forms a cluster that manages the development of a variety of products across the cancer diagnostic value chain. From screening and risk identification, through diagnostics, personalized medicine, and monitoring disease recurrence, Micromedic identifies projects that fill unmet needs in various cancer related indications, and turns them into viable marketable products. Micromedic operates through strategic collaborations and in-licensing from scientific institutes world-wide as well as in-house based research.
Employees
18
Date Price Change Volume
26-11-12 ILA 32.60 -2.40% 97,405
26-11-11 ILA 33.40 0.00% 100
26-11-10 ILA 33.40 +0.30% 200
26-11-09 ILA 33.30 0.00% 53,889
26-11-06 ILA 33.30 -0.30% 33,185
  1. Stock Market
  2. Stocks
  3. NXTG Stock